Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessBMO Capital Downgrades DOW (NYSE:DOW) Amid Market Performance Concerns

BMO Capital Downgrades DOW (NYSE:DOW) Amid Market Performance Concerns

Add to Favorite
Added to Favorite


BMO Capital downgraded DOW (NYSE:DOW) from “Market Perform” to “Perform” with a current stock price of $40.09.
The Dow Jones Industrial Average, including DOW, is expected to underperform compared to the S&P 500 and Nasdaq Composite despite its appeal for stability and dividends.
DOW’s market capitalization stands at approximately $27.72 billion, with a recent price decrease reflecting market volatility.

On December 25, 2024, BMO Capital downgraded DOW (NYSE:DOW) from “Market Perform” to “Perform,” with the stock priced at $40.09. This change was reported by Benzinga in an article titled “Top 7 Blue-Chip Stocks With The Best Return Potential Going Into 2025.” DOW is a part of the Dow Jones Industrial Average, a collection of blue-chip stocks known for their stability and dividends.

As 2024 ends, the Dow Jones Industrial Average is expected to underperform compared to the S&P 500 and Nasdaq Composite. Over the past five years, the Dow has returned 68.2%, which is lower than the S&P 500’s 102.8% and Nasdaq’s 132.7%. Despite this, Dow stocks remain attractive for their stability and dividends, appealing to investors seeking quality blue-chip companies.

DOW’s current price on the NYSE is $39.60, reflecting a decrease of approximately 1.09% from the previous day. The stock has seen a decline of $0.44 today, with a trading range between $39.23 and $39.92. Over the past year, DOW’s price has fluctuated between a high of $60.69 and a low of $38.85, indicating some volatility.

The company’s market capitalization is approximately $27.72 billion, with a trading volume of 5,158,785 shares. Despite the recent downgrade and price fluctuations, DOW remains a part of the Dow Jones Industrial Average, which includes industry leaders like McDonald’s, The Home Depot, and Chevron. These companies are valued for their stability and potential to generate passive income through dividends.

For investors interested in passive income, dividend stocks like McDonald’s, The Home Depot, and Chevron are worth considering. An investment of $3,500 in each of these Dow stocks could yield over $325 in passive income in 2025. This highlights the appeal of Dow stocks for those seeking steady returns in uncertain markets.

Subscribe to get Latest News Updates

Latest News

You may like more
more

Sangamo Shares Plummet 56 percent as Pfizer Ends Hemophilia A Gene Therapy Partnership

Sangamo Therapeutics (NASDAQ:SGMO) faced a significant setback as Pfizer...

Astera Labs Downgraded to Market Perform Amid Valuation Concerns

Northland analysts downgraded Astera Labs (NASDAQ:ALAB) from Outperform to...